• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Vaccines, Blood & Biologics

  • Print
  • Share
  • E-mail

Clarification regarding AE tables Email, October 05, 2009 - Laviv

From: Jeanne Novak [jnovak@cbrintl.com]
Sent: Monday, October 05, 2009 4:43 PM
To: Haudenschild, Changting
Cc: Tull, Lori; Dana Weinberger; Jeanne Novak
Subject: Clarification regarding AE tables

Importance: High

Dear Changting,
 
As you know, we originally emailed draft tables regarding rare (<1%) related
adverse events to Dr. Zhu on 9/30/09, and we emailed revised, final versions to
Dr. Zhu on 10/2/09.  We also made a formal submission (BLA 125348; Amendment 13)
of these AE tables for delivery to the document control room tomorrow.
 
You also emailed draft slides that you prepared on this topic on Oct. 1st, and
we discussed the impact of changes made to the tables on the draft slides by
phone on Oct. 2nd.  Further to the discussion on Oct. 2nd, we wanted to note
that the following changes were made to Table 1: events for the preferred terms
?erythema?, ?post procedural dizziness?, and ?post procedural headache? were
added to the final version relative to the original draft version.  Only the
event of ?post procedural headache? occurred in Studies IT-R-005 or IT-R-006
(the other two did not occur in these studies).  Post procedural headache was
reported for subject -b(6)-.  As such, we think that the addition of the event
of ?post procedural headache? may have an impact on the draft slides regarding
AEs in Studies IT-R-005 and IT-R-006 that you provided.
 
We hope this information helps your review.  Please feel free to contact me with
any questions or requests.
 
Best regards,
 
Jeanne
 
 
Jeanne M. Novak, Ph.D.
Owner and Principal Consultant
CBR International Corp.?
720-746-1190
720-746-1192 (Fax)
www.cbrintl.com
 
This electronic transmission (including any and all attachments) is intended
solely for the use of the individual or entity to whom it is addressed and may
contain information that is privileged and/or confidential. If you are not the
intended recipient of this electronic transmission, you are hereby notified that
any disclosure, copying or distribution, or the taking of any action in reliance
upon the contents of this electronic transmission, is strictly prohibited, and
you are further requested to purge this electronic transmission and all copies
thereof from your computer system.